Literature DB >> 25692725

Unique features of mutations revealed by sequentially reprogrammed induced pluripotent stem cells.

Shuai Gao1, Caihong Zheng2, Gang Chang3, Wenqiang Liu4, Xiaochen Kou4, Kun Tan5, Li Tao5, Kai Xu4, Hong Wang4, Jun Cai2, Jianhui Tian5, Shaorong Gao6.   

Abstract

Although viable mice can be generated from induced pluripotent stem cells (iPSCs), the impact of accumulated mutations on the developmental potential of the resulting iPSCs remains to be determined. Here, we demonstrate that all-iPSC mice generated through tetraploid blastocysts complementation can tolerate the accumulation of somatic mutations for up to six generations using a Tet-on inducible reprogramming system. But, the viability of the all-iPS mice decreased with increasing generations. A whole-genome sequencing survey revealed that thousands of single-nucleotide variations (SNVs), including 44 non-synonymous ones, accumulated throughout the sequential reprogramming process. Subsequent analysis provides evidence that these accumulated SNVs account for the gradual reduction in viability of the resultant all-iPSC mice. Unexpectedly, our present reprogramming system revealed that pluripotent stem cells are heterogeneous in terms of possessing a set of copy-number alterations (CNAs). These CNAs are unique for pluripotent cells and subsequently disappear in the differentiating progenies.

Entities:  

Mesh:

Year:  2015        PMID: 25692725     DOI: 10.1038/ncomms7318

Source DB:  PubMed          Journal:  Nat Commun        ISSN: 2041-1723            Impact factor:   14.919


  11 in total

Review 1.  Report of the Key Opinion Leaders Meeting on Stem Cell-derived Beta Cells.

Authors:  Jon Odorico; James Markmann; Douglas Melton; Julia Greenstein; Albert Hwa; Cristina Nostro; Alireza Rezania; Jose Oberholzer; Daniel Pipeleers; Luhan Yang; Chad Cowan; Danwei Huangfu; Dieter Egli; Uri Ben-David; Ludovic Vallier; Shane T Grey; Qizhi Tang; Bart Roep; Camilo Ricordi; Ali Naji; Giuseppe Orlando; Daniel G Anderson; Mark Poznansky; Barbara Ludwig; Alice Tomei; Dale L Greiner; Melanie Graham; Melissa Carpenter; Giovanni Migliaccio; Kevin D'Amour; Bernhard Hering; Lorenzo Piemonti; Thierry Berney; Mike Rickels; Thomas Kay; Ann Adams
Journal:  Transplantation       Date:  2018-08       Impact factor: 4.939

2.  β-Cell Replacement in Mice Using Human Type 1 Diabetes Nuclear Transfer Embryonic Stem Cells.

Authors:  Lina Sui; Nichole Danzl; Sean R Campbell; Ryan Viola; Damian Williams; Yuan Xing; Yong Wang; Neil Phillips; Greg Poffenberger; Bjarki Johannesson; Jose Oberholzer; Alvin C Powers; Rudolph L Leibel; Xiaojuan Chen; Megan Sykes; Dieter Egli
Journal:  Diabetes       Date:  2017-09-20       Impact factor: 9.337

3.  Integrated analysis of hematopoietic differentiation outcomes and molecular characterization reveals unbiased differentiation capacity and minor transcriptional memory in HPC/HSC-iPSCs.

Authors:  Shuai Gao; Xinfeng Hou; Yonghua Jiang; Zijian Xu; Tao Cai; Jiajie Chen; Gang Chang
Journal:  Stem Cell Res Ther       Date:  2017-01-23       Impact factor: 6.832

4.  High throughput sequencing identifies an imprinted gene, Grb10, associated with the pluripotency state in nuclear transfer embryonic stem cells.

Authors:  Hui Li; Shuai Gao; Hua Huang; Wenqiang Liu; Huanwei Huang; Xiaoyu Liu; Yawei Gao; Rongrong Le; Xiaochen Kou; Yanhong Zhao; Zhaohui Kou; Jia Li; Hong Wang; Yu Zhang; Hailin Wang; Tao Cai; Qingyuan Sun; Shaorong Gao; Zhiming Han
Journal:  Oncotarget       Date:  2017-07-18

Review 5.  Bringing Neural Cell Therapies to the Clinic: Past and Future Strategies.

Authors:  Stefan Irion; Susan E Zabierowski; Mark J Tomishima
Journal:  Mol Ther Methods Clin Dev       Date:  2016-12-24       Impact factor: 6.698

6.  Genetic aberrations in iPSCs are introduced by a transient G1/S cell cycle checkpoint deficiency.

Authors:  Ryoko Araki; Yuko Hoki; Tomo Suga; Chizuka Obara; Misato Sunayama; Kaori Imadome; Mayumi Fujita; Satoshi Kamimura; Miki Nakamura; Sayaka Wakayama; Andras Nagy; Teruhiko Wakayama; Masumi Abe
Journal:  Nat Commun       Date:  2020-01-10       Impact factor: 14.919

7.  Genome-wide gene expression analyses reveal unique cellular characteristics related to the amenability of HPC/HSCs into high-quality induced pluripotent stem cells.

Authors:  Shuai Gao; Li Tao; Xinfeng Hou; Zijian Xu; Wenqiang Liu; Kun Zhao; Mingyue Guo; Hong Wang; Tao Cai; Jianhui Tian; Shaorong Gao; Gang Chang
Journal:  Stem Cell Res Ther       Date:  2016-03-15       Impact factor: 6.832

8.  Prognostic value of circulating tumour DNA in patients undergoing curative resection for pancreatic cancer.

Authors:  Naoto Hadano; Yoshiaki Murakami; Kenichiro Uemura; Yasusi Hashimoto; Naru Kondo; Naoya Nakagawa; Taijiro Sueda; Eiso Hiyama
Journal:  Br J Cancer       Date:  2016-06-09       Impact factor: 7.640

9.  Lower genomic stability of induced pluripotent stem cells reflects increased non-homologous end joining.

Authors:  Minjie Zhang; Liu Wang; Ke An; Jun Cai; Guochao Li; Caiyun Yang; Huixian Liu; Fengxia Du; Xiao Han; Zilong Zhang; Zitong Zhao; Duanqing Pei; Yuan Long; Xin Xie; Qi Zhou; Yingli Sun
Journal:  Cancer Commun (Lond)       Date:  2018-07-25

10.  DSMNC: a database of somatic mutations in normal cells.

Authors:  Xuexia Miao; Xi Li; Lifei Wang; Caihong Zheng; Jun Cai
Journal:  Nucleic Acids Res       Date:  2019-01-08       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.